124 Views | 38 Downloads
David S Yu: Tel: +1 404 778 1758; Fax: +1 404 778 5520; Email: dsyu@emory.edu
P.E.H. and D.S.Y. conceived and designed the study. P.E.H., P.K., N.P.G., S.K.R., N.C.L., R.H.S.J., H.Z., F.S., S.W., D.M.D., W.D., E.V.M., B.S., D.D., X.L. and D.M.S. performed and analyzed the experiments. P.E.H., P.K., N.P.G., S.K.R., N.C.L., H.Z., F.S., S.W., D.M.D., W.D., E.V.M., B.S., D.D., X.L., S.L., E.A.O., N.T.S., D.M.S., Y.W., X.D., W.S.D., B.E., A.J.D. and D.S.Y. interpreted the findings. P.E.H., P.K. and D.S.Y. wrote the manuscript with input from all authors.
We thank members of the Yu lab for helpful discussion. We kindly thank Manfred Jung for SirReal2 inhibitor, Eric Verdin for the SIRT2-FLAG plasmid, Anthony Davis for DNA-PKcs antibody, DNA-PKcs and Ku70/80 plasmids, and DNA-PKcs-GFP stable cell lines (both U2OS and CHO V3), and Roger Greenberg for mCherry-LacI-FokI U2OS reporter cells integrated with lac operator repeats.
Conflict of interest statement. None declared.
National Institutes of Health (NIH)/National Cancer Institute (NCI) [R01CA178999, R01CA254403]; Department of Defense (DOD) Ovarian Cancer Research Program (OCRP) [OC160540]; DOD Breast Cancer Research Program (BCRP) [BC180883]; Basser Center for BRCA External Research Grant Program Innovation Award 32356; Winship Cancer Institute (WCI) Brenda Nease Breast Cancer Research Fund Pilot Award [53237 to D.S.Y.]; NIH/National Institutes of General Medical Sciences (NIGMS) [T32GM008490 to P.E.H.]; NIH/NCI [CA92584, CA162804]; NIH/NIGMS [GM047251 to A.D.]. Funding for open access charge: Startup Funding.
© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.